Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 108 results for "sudhir agrawal"

Short-term income or dynamic bond funds are best picks: Sudhir...

Q&A with Fund Manager (Fixed Income), UTI MF Jinsy Mathew | Mumbai October 20, 2014 Last Updated at 13:58 IST At a time when equity markets are hovering close to their all-time highs, investments into the debt market are frowned upon by retail investors. Business Standard, 1 week ago

Expect rupee to trade in 59-62/$ range: Sudhir Agrawal, UTI MF

'We are seeing a decent amount of flows in both equity as well as debt markets, and that is happening because of improving fundamentals.' In a chat with ET Now, Sudhir Agrawal, Fund Manager-Fixed Income, UTI MF, shares his outlook on the IIP numbers and ...
 Economic Times3 weeks ago

​4.1% fiscal deficit target a bit ambitious, but Govt may achieve it: Sudhir Agrawal, UTI MF

In a chat with ET Now, Sudhir Agrawal, Fund Manager-Fixed Income, UTI MF, shares his views on the government's fiscal deficit target. Excerpts: ET Now: The Finance Minister is saying that the government is confident of meeting the fiscal target of ...
 Economic Times1 month ago

Lead indicators are suggesting growth is picking up: Sudhir Agrawal, UTI MF

We also feel that this quarter GDP may surprise on the upside and we may see close to around 6% GDP growth for the last quarter. In a chat with ET Now, Sudhir Agrawal, Fund Manager-Fixed Income, UTI MF, shares his macroeconomic outlook. Excerpts: ET Now: Is ...
 Economic Times2 months ago

Alterations in Gene Array Patterns in Dendritic Cells from Aged Humans

by Jia-ning Cao, Anshu Agrawal, Edward Sharman, Zhenyu Jia, Sudhir Gupta Dendritic cells (DCs) are major antigen-presenting cells that play a key role in initiating and regulating innate and adaptive immune responses. DCs are critical mediators of ...
 Plosone.org1 month ago
News India Times

Arrest of Indian banker rattles lenders

By Anoop Agrawal and Anto Antony MUMBAI, India — The arrest of an Indian banker amid probes into lending violations looks set to prompt tighter loan approvals that may deepen the worst credit slowdown since 2009. Federal investigators ...
 News India Times2 months ago
Samaylive

Maharashtra Assembly election 2014 results: Constituency-wise winning candidates list

1 Akkalkuwa Padavi Adv. K.C. (Cong) 2 Shahada PADVI UDESING KOCHARU (BJP) 3 Nandurbar GAVIT VIJAYKUMAR KRUSHNARAO (BJP) 4 Nawapur NAIK SURUPSING HIRYA (Cong) 5 Sakri AHIRE DHANAJI SITARAM OR D.S.AHIRE (Cong) 6 Dhule ...
 Samaylive1 week ago Results of Maharashtra Assembly polls 2014  India Today1 week ago Constituency Wise Results  ZeeNews.com1 week ago Maharashtra Assembly Polls:BJP iss..  Samaylive4 weeks ago
[x]  

Idera advances its second TLR therapeutic

CAMBRIDGE, Mass.—, a clinical-stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and rare diseases, today announced it has advanced IMO-9200 into Phase 1 clinical development following acceptance of an ...
 Drug Discovery News1 week ago Idera Pharmaceuticals Expands Pipeline by Initiating Clinical Development of Proprietary TLR Antagonist Candidate IMO-9200  Pettinga Financial Advisors2 weeks ago Idera Pharmaceuticals, Inc. Expands Pipeline by Initiating Clinical Development of Proprietary TLR Antagonist Candidate IMO-9200  BioSpace2 weeks ago IDERA PHARMACEUTICALS : Expands Pipeline by Initiating Clinical Development of Proprietary TLR Antagonist Candidate IMO-9200  4 Traders2 weeks ago
[x]  

Idera Pharmaceuticals Inc. (IDRA) Jumps 6.82% on October 16

Idera Pharmaceuticals Inc. ( IDRA ) was among the biggest gainers on the Russell 2000 for October 16 as the stock popped 6.82% to $2.35, representing a gain of $0.15 per share. Some 816,259 shares traded hands on 2,641 trades, compared with an ...
 Equities.com2 weeks ago Idera Pharmaceuticals Inc. (IDRA) Drops 5.68% on October 1  Equities.com4 weeks ago

Idera Pharmaceuticals : Patent Issued for Toll like Receptor Modulators

By a News Reporter-Staff News Editor at Life Science Weekly -- Idera Pharmaceuticals, Inc. ( Cambridge, MA ) has been issued patent number 8853375, according to news reporting originating out of Alexandria, Virginia , by NewsRx editors (see also ...
 4 Traders2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less